| Name |
ALS-PCS v5.3 - Hypoglycemia Medical Directive |
| Description |
In response to a critical shortage of intramuscular (IM) glucagon, intranasal (IN) glucagon has been approved and added to the Hypoglycemia Medical Directive. The MOH released this on February 9, 2024, in the Advanced Life Support Patient Care Standards v5.3. |
| License |
|
| File name |
ALS PCS v5.3 Memo IN Glucagon 15.2.24.pdf |
| Version |
5.3 |
| Size |
553.65 KB |
| File type |
pdf (Mime type application/pdf) |
| Owner |
Niall Sheehan |
| Date added |
20/02/2024 06:25:11 |
| Hits |
3289 |
| Last modified on |
21/02/2024 06:50:15 |
| MD5 checksum |
13dc301cd054fe778c97d3bb777bfa4d |
